4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-2-ol, 95.0%, 5g

4-BROMO-2-CHLOROCINNAMIC ACID, 95%, 5g

Sodium 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate, 72.0%, 25g

Analytical and precision balance Pioneer® series Models with internal adjustment, factory calibrated, 0.1 g, 4200 g, PX4201

5-Amino-2-bromoisonicotinic acid, 95.0%, 1g

Methyl 12-bromododecanoate, 97.0%, 1g

5-tert-Butyl 2-ethyl 6,7-dihydrothiazolo[5,4-c]pyridine-2,5(4H)-dicarboxylate, 95.0%, 250mg

Tetramethylurea, min. 99%, for synthesis, 250 ml, glass packaging

4-(1H-Pyrazol-4-yl)benzoic acid, 97.0%, 5g

(S)-tert-Butyl 4-isobutyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 95%, 100mg

1-Phenyl-2-pyrimidin-4-yl ethanone, 95.0%, 1g

3-Bromo-6-methoxy-2,4-dimethylpyridine, 95.0%, 1g

4-Acetamido-2-methylbenzoic acid, 96.0%, 25g